VCAM-1

Vingroup to Announce a Pioneering Solution to Optimize Cameras Under Display

Wednesday, September 16, 2020 - 3:00pm

Pioneering AI technologies enable the realisation of ultimate infinity display experience, and make VinSmart one of the first companies in the world to own a smartphone with a camera under display.

Key Points: 
  • Pioneering AI technologies enable the realisation of ultimate infinity display experience, and make VinSmart one of the first companies in the world to own a smartphone with a camera under display.
  • VCam Kristal is a pioneering AI photography technology successfully developed by VinAI Research, allowing high-quality photography with cameras under display (CUD).
  • By incorporating AI algorithms and models in computer vision, computational photography, and special neural network architecture, VCam Kristal overcomes optical barriers of cameras under display.
  • VCam Kristal marks an important breakthrough in AI camera technology on cell phones, opening up opportunities to commercialise high-quality cell phones with cameras under display while realising an infinity display experience.

VCAM-1 (Vascular Cell Adhesion Molecule-1) Gene Expression Inhibitor - Pipeline Insight, 2019 - ResearchAndMarkets.com

Tuesday, January 22, 2019 - 12:14pm

The "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor -Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor development.
  • The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
  • The report assesses the active VCAM-1 (vascular cell adhesion molecule-1) gene expression inhibitor pipeline products by developmental stage, product type, molecule type, and administration route.